Teleflex Incorporated Introduces LMA Protector Airway, A New Standard In LMA Airway Management Devices

Versatile, single-use LMA^® Airway features dual gastric channel, silicone cuff with dynamic fixed curve, integrated Cuff Pilot™ Technology and endotracheal tube (ETT) intubation capability

Global leader in supraglottic airway solutions also expands its line of single-use LMA Unique^® Airways, which have been used in millions of cases by thousands of clinicians

WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies for critical care and surgery, has announced the introduction of the LMA Protector™ Airway, a highly versatile single-use laryngeal mask that combines our most advanced airway management innovations for patient care and safety in one easy-to-use device. Teleflex will demonstrate the LMA Protector™ Airway at ANESTHESIOLOGY^® 2015, the annual organization meeting of the American Society of Anesthesiologists^® (ASA).

“The LMA Protector™ Airway ushers in a new era in the evolution of airway management with its unique combination of innovative capabilities that could help clinicians reduce airway-related complications and improve procedural efficiencies”

Teleflex will also launch new products in the LMA Unique^® Line of Airways, which have been used in millions of cases by thousands of clinicians worldwide, as well as the ARROW Endurance™ Extended Dwell Peripheral Catheter System for patients needing reliable vascular access for up to 29 days. Also featured at the meeting will be other Arrow^®, LMA^®, Rusch^® and Hudson RCI^® Branded Products from Teleflex that offer solutions for airway management, respiratory therapy, vascular access and pain management.

“The LMA Protector™ Airway ushers in a new era in the evolution of airway management with its unique combination of innovative capabilities that could help clinicians reduce airway-related complications and improve procedural efficiencies,” said Justin McMurray, President of the Teleflex Anesthesia Division. “This significant advance in airway management is the direct result of our relentless pursuit of innovations to improve the health and quality of people’s lives.”

LMA^® Airways have been a global leader in airway management solutions for anesthesia since 1981, when the original LMA^® Airway was invented. The LMA Protector™ Airway is the most advanced second generation LMA^® Airway and was designed with enhanced safety features.

About the LMA Protector™ Airway

The LMA Protector™ Airway is the world’s first single-use laryngeal mask with a dual gastric drainage channel and pharyngeal chamber designed specifically to channel high volume, high pressure gastric contents away from the airway. The 4th National Audit Project of the Royal College of Anaesthetists and the Difficult Airway Society (NAP4) has recommended that all hospitals have supraglottic airway devices with gastric access available for both routine and rescue airway management.¹

With a 100% silicone cuff and airway tube, the LMA Protector™ Airway is designed for easy, rapid insertion and a secure fit, even in difficult airway situations. Its elongated cuff is designed to conform to the contours of the hypopharynx and, together with our First Seal™ Technology, achieve pressures equivalent to the LMA ProSeal^® Airway. It also integrates Second Seal™ Technology to secure the distal tip at the upper esophageal sphincter, isolating the respiratory tract from the digestive tract and reducing the risk of aspiration of gastric contents.

The LMA Protector™ Airway also includes Cuff Pilot™ Technology, a cuff pressure indicator for single-use airway management devices. This enables clinicians to confirm that the inserted cuff is properly inflated and to monitor pressure levels.

The LMA Protector™ is designed for insertion without the need for any guidance tools and has the flexibility to remain in place when the patient’s head is moved in any direction. It also allows for intubation with ETTs up to 7.5 mm to provide a safe and effective option for airway replacement.

Potential uses for the new LMA Protector™ Airway include:

• More difficult cases where an ETT may otherwise be used for patients with GERD
• Cases for which Positive Pressure Ventilation (PPV) may be required
• Clinicians who want the ease of a single-use silicone cuff to reduce the likelihood of throat irritation and stimulation
• Clinicians who want continuous cuff pressure monitoring to reduce the likelihood of over inflation

Other New LMA^® and Arrow^® Products

In addition to the LMA Protector™ Airway, Teleflex will be featuring the following new products from the LMA^® and Arrow^® Brands at The ANESTHESIOLOGY^® 2015 annual meeting.

LMA Unique^® (Silicone Cuff) Airway with Cuff Pilot™ Technology

The LMA Unique^® (Silicone Cuff) Airway combines all of the features of a high-quality supraglottic airway device with the benefits of silicone, which include higher seal pressures and enhanced conformity to the patient’s anatomy. The LMA Unique^® (Silicone Cuff) Airway also features Cuff Pilot™ Technology, an integrated cuff pressure monitor system.

LMA^® Unique EVO™ Airway with Intubation Capabilities

The LMA^® Unique EVO™ Airway is a first generation supraglottic airway device that also offers endotracheal tube (ETT) intubation capabilities. Made with a silicone cuff and PVC airway tube, it allows for intubation with ETT sizes 7.0 - 8.0 mm and features Cuff Pilot™ Technology, an integrated cuff pressure monitor system.

ARROW Endurance™ Extended Dwell Peripheral Catheter System

The new ARROW Endurance™ System gives hospitals and physicians a third option for reliable vascular access for up to 29 days. It is intended for patients who need longer dwell times than a traditional peripheral intravenous (PIV) catheter allows but do not require a peripherally inserted central catheter (PICC), which is associated with increased clinical risks and expenses.

About Teleflex Incorporated

Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit teleflex.com.

Teleflex is the home of Arrow^®, Deknatel^®, Hudson RCI^®, LMA^®, Pilling^®, Rusch^® and Weck^® – trusted brands united by a common sense of purpose.

Forward-Looking Statements

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Any forward-looking statements contained herein are based on our management’s current beliefs and expectations, but are subject to a number of risks, uncertainties and changes in circumstances, which may cause actual results or company actions to differ materially from what is expressed or implied by these statements. These risks and uncertainties are identified and described in more detail in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K.

American Society of Anesthesiologists and ANESTHESIOLOGY are trademarks or registered trademarks of American Society of Anesthesiologists.

Teleflex, the Teleflex logo, Arrow, Deknatel, Hudson RCI, LMA, Pilling, Rusch, Weck, Arrow Endurance, Cuff Pilot, First Seal, LMA ProSeal, LMA Protector, LMA Unique, Second Seal and Unique EVO are trademarks or registered trademarks of Teleflex Incorporated or its affiliates, in the U.S. and/or other countries.

© 2015 Teleflex Incorporated. All rights reserved. MC-001690

References:

1. 4th National Audit Project of the Royal College of Anaesthetists and the Difficult Airway Society: Major Complications of Airway Management in the United Kingdom. Report and findings: March 2011. Editors: Dr Tim Cook, Dr Nick Woodall and Dr Chris Frerk.